Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Nature Medicine
|
July 25, 2018
Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia
Nikos Kourtis, Charalampos Lazaris, Kathryn Hockemeyer, et al.
Nature Communications
|
November 23, 2022
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies
Yonina R Murciano-Goroff, Alison M Schram, Ezra Y Rosen, et al.
Nature Immunology
|
August 14, 2019
The E3 ubiquitin ligase SPOP controls resolution of systemic inflammation by triggering MYD88 degradation
Maria Guillamot, Dahmane Ouazia, Igor Dolgalev, et al.
Cell Stem Cell
|
January 19, 2022
TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity
Tomoya Muto, Maria Guillamot, Jennifer Yeung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2024
Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets
Monica F Chen, Soo-Ryum Yang, Jessica J Tao, et al.
Nature
|
August 17, 2022
Ordered and deterministic cancer genome evolution after p53 loss
Timour Baslan, John P Morris, Zhen Zhao, et al.
Nature Communications
|
March 19, 2022
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
Ezra Y Rosen, Helen H Won, Youyun Zheng, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Nature Medicine
|
July 25, 2018
Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia
Nikos Kourtis, Charalampos Lazaris, Kathryn Hockemeyer, et al.
Nature Communications
|
November 23, 2022
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies
Yonina R Murciano-Goroff, Alison M Schram, Ezra Y Rosen, et al.
Nature Immunology
|
August 14, 2019
The E3 ubiquitin ligase SPOP controls resolution of systemic inflammation by triggering MYD88 degradation
Maria Guillamot, Dahmane Ouazia, Igor Dolgalev, et al.
Cell Stem Cell
|
January 19, 2022
TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity
Tomoya Muto, Maria Guillamot, Jennifer Yeung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2024
Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets
Monica F Chen, Soo-Ryum Yang, Jessica J Tao, et al.
Nature
|
August 17, 2022
Ordered and deterministic cancer genome evolution after p53 loss
Timour Baslan, John P Morris, Zhen Zhao, et al.
Nature Communications
|
March 19, 2022
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
Ezra Y Rosen, Helen H Won, Youyun Zheng, et al.
Page
of 2